v3.24.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (loss)
Accumulated Deficit
Balance at the beginning of the period (in shares) at Dec. 31, 2022   541,364,000      
Balance at the beginning of the period at Dec. 31, 2022 $ 1,472,956 $ 53 $ 2,082,373 $ (7,237) $ (602,233)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of options (in shares)   803,000      
Issuance of common stock upon exercise of options 1,051   1,051    
Issuance of common stock net settlement of restricted stock units (in shares)   1,470,000      
Issuance of common stock upon net settlement of restricted stock units (3,746)   (3,746)    
Vesting of common stock warrants 2,102   2,102    
Share-based compensation 33,906   33,906    
Executive chairman long-term performance award 13,121   13,121    
Repurchase and retirement of common stock, including excise tax (in shares)   (3,206,000)      
Repurchase and retirement of common stock, including excise tax (20,993)   (20,993)    
Change in accumulated other comprehensive income (loss) 4,054     4,054  
Net income (loss) (68,801)       (68,801)
Balance at the end of the period (in shares) at Mar. 31, 2023   540,432,000      
Balance at the end of the period at Mar. 31, 2023 1,433,650 $ 53 2,107,814 (3,183) (671,034)
Balance at the beginning of the period (in shares) at Dec. 31, 2022   541,364,000      
Balance at the beginning of the period at Dec. 31, 2022 1,472,956 $ 53 2,082,373 (7,237) (602,233)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Change in accumulated other comprehensive income (loss) 5,399        
Net income (loss) (182,587)        
Balance at the end of the period (in shares) at Sep. 30, 2023   526,586,000      
Balance at the end of the period at Sep. 30, 2023 1,295,083 $ 53 2,081,689 (1,838) (784,821)
Balance at the beginning of the period (in shares) at Mar. 31, 2023   540,432,000      
Balance at the beginning of the period at Mar. 31, 2023 1,433,650 $ 53 2,107,814 (3,183) (671,034)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of options (in shares)   828,000      
Issuance of common stock upon exercise of options 1,310   1,310    
Issuance of common stock under employee stock purchase plan (in shares)   446,000      
Issuance of common stock under employee stock purchase plan 1,775   1,775    
Issuance of common stock net settlement of restricted stock units (in shares)   2,679,000      
Issuance of common stock upon net settlement of restricted stock units (6,324)   (6,324)    
Vesting of common stock warrants 2,372   2,372    
Share-based compensation 32,152   32,152    
Executive chairman long-term performance award 13,267   13,267    
Repurchase and retirement of common stock, including excise tax (in shares)   (10,168,000)      
Repurchase and retirement of common stock, including excise tax (48,497) $ (1) (48,496)    
Change in accumulated other comprehensive income (loss) 1,707     1,707  
Net income (loss) (58,797)       (58,797)
Balance at the end of the period (in shares) at Jun. 30, 2023   534,217,000      
Balance at the end of the period at Jun. 30, 2023 1,372,615 $ 52 2,103,870 (1,476) (729,831)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of options (in shares)   1,189,000      
Issuance of common stock upon exercise of options 1,675   1,675    
Repurchase of early exercised stock options (in shares)   (3,000)      
Repurchase of early exercised stock options (6)   (6)    
Issuance of common stock net settlement of restricted stock units (in shares)   2,645,000      
Issuance of common stock upon net settlement of restricted stock units (8,481) $ 2 (8,483)    
Vesting of common stock warrants 2,284   2,284    
Share-based compensation 33,383   33,383    
Executive chairman long-term performance award 13,413   13,413    
Repurchase and retirement of common stock, including excise tax (in shares)   (11,463,000)      
Repurchase and retirement of common stock, including excise tax (64,448) $ (1) (64,447)    
Change in accumulated other comprehensive income (loss) (362)     (362)  
Net income (loss) (54,990)       (54,990)
Balance at the end of the period (in shares) at Sep. 30, 2023   526,586,000      
Balance at the end of the period at Sep. 30, 2023 1,295,083 $ 53 2,081,689 (1,838) (784,821)
Balance at the beginning of the period (in shares) at Dec. 31, 2023   520,343,000      
Balance at the beginning of the period at Dec. 31, 2023 1,243,395 $ 52 2,067,776 762 (825,195)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of options (in shares)   98,000      
Issuance of common stock upon exercise of options 49   49    
Issuance of common stock net settlement of restricted stock units (in shares)   2,806,000      
Issuance of common stock upon net settlement of restricted stock units (10,917)   (10,917)    
Vesting of common stock warrants 2,100   2,100    
Share-based compensation 33,393   33,393    
Executive chairman long-term performance award 13,121   13,121    
Repurchase and retirement of common stock, including excise tax (in shares)   (5,238,000)      
Repurchase and retirement of common stock, including excise tax (32,830)   (32,830)    
Change in accumulated other comprehensive income (loss) (1,586)     (1,586)  
Net income (loss) (36,060)       (36,060)
Balance at the end of the period (in shares) at Mar. 31, 2024   518,009,000      
Balance at the end of the period at Mar. 31, 2024 1,210,665 $ 52 2,072,692 (824) (861,255)
Balance at the beginning of the period (in shares) at Dec. 31, 2023   520,343,000      
Balance at the beginning of the period at Dec. 31, 2023 1,243,395 $ 52 2,067,776 762 (825,195)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Change in accumulated other comprehensive income (loss) 71        
Net income (loss) 54,405        
Balance at the end of the period (in shares) at Sep. 30, 2024   504,150,000      
Balance at the end of the period at Sep. 30, 2024 1,095,658 $ 50 1,865,565 833 (770,790)
Balance at the beginning of the period (in shares) at Mar. 31, 2024   518,009,000      
Balance at the beginning of the period at Mar. 31, 2024 1,210,665 $ 52 2,072,692 (824) (861,255)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of options (in shares)   33,000      
Issuance of common stock upon exercise of options 59   59    
Issuance of common stock under employee stock purchase plan (in shares)   327,000      
Issuance of common stock under employee stock purchase plan 1,629   1,629    
Issuance of common stock net settlement of restricted stock units (in shares)   3,338,000      
Issuance of common stock upon net settlement of restricted stock units (9,370)   (9,370)    
Share-based compensation 38,209   38,209    
Executive chairman long-term performance award (157,738)   (157,738)    
Repurchase and retirement of common stock, including excise tax (in shares)   (10,959,000)      
Repurchase and retirement of common stock, including excise tax (59,738) $ (1) (59,737)    
Change in accumulated other comprehensive income (loss) (449)     (449)  
Net income (loss) 119,108       119,108
Balance at the end of the period (in shares) at Jun. 30, 2024   510,748,000      
Balance at the end of the period at Jun. 30, 2024 1,142,375 $ 51 1,885,744 (1,273) (742,147)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of options (in shares)   11,000      
Issuance of common stock upon exercise of options 13   13    
Issuance of common stock net settlement of restricted stock units (in shares)   2,790,000      
Issuance of common stock upon net settlement of restricted stock units (8,756)   (8,756)    
Vesting of common stock warrants 322   322    
Share-based compensation 37,145   37,145    
Repurchase and retirement of common stock, including excise tax (in shares)   (9,399,000)      
Repurchase and retirement of common stock, including excise tax (48,904) $ (1) (48,903)    
Change in accumulated other comprehensive income (loss) 2,106     2,106  
Net income (loss) (28,643)       (28,643)
Balance at the end of the period (in shares) at Sep. 30, 2024   504,150,000      
Balance at the end of the period at Sep. 30, 2024 $ 1,095,658 $ 50 $ 1,865,565 $ 833 $ (770,790)